<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is the fourth most common cause of <z:hpo ids='HP_0011420'>death</z:hpo> from <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in the world </plain></SENT>
<SENT sid="1" pm="."><plain>The limitations of the currently available methods and biomarkers for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> management highlight the necessity of finding novel markers </plain></SENT>
<SENT sid="2" pm="."><plain>Metabonomics can be used to search for potential markers that can provide molecular insight into human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The emergence of two-dimensional gas chromatography time of flight mass spectrometry (GC × GC/TOFMS) has comprehensively enhanced the metabolic space coverage of conventional GC/MS </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, a GC × GC/TOFMS was developed for the tissue-based global metabonomic profiling of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>A <z:chebi fb="140" ids="39299">Pegasus</z:chebi> GC × GC/TOFMS (Leco Corp., St </plain></SENT>
<SENT sid="6" pm="."><plain>Joseph, MI, USA) system comprising an Agilent 7890 GC and <z:chebi fb="140" ids="39299">Pegasus</z:chebi> IV TOFMS was used for this purpose </plain></SENT>
<SENT sid="7" pm="."><plain>An Agilent DB-1 (30 m × 250 μm × 0.25 μm) <z:chebi fb="0" ids="46729">fused silica</z:chebi> capillary column and a Restek Rxi®-17 (1 m × 100 μm × 0.10 μm) <z:chebi fb="0" ids="46729">fused silica</z:chebi> capillary column were used as the primary and secondary columns, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>The method was applied for global metabonomic profiling of matched <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> tissues (n = 63) obtained from 31 CRC patients during surgery </plain></SENT>
<SENT sid="9" pm="."><plain>An attempt was also made to compare GC × GC/TOFMS with GC/MS and NMR in similar application </plain></SENT>
<SENT sid="10" pm="."><plain>The results showed that the metabotype associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is distinct from that of <z:mpath ids='MPATH_458'>normal</z:mpath> tissue and led to the identification of chemically diverse marker metabolites </plain></SENT>
<SENT sid="11" pm="."><plain>Metabolic pathway mapping suggested deregulation of various biochemical processes such as glycolysis, Krebs cycle, osmoregulation, steroid biosynthesis, eicosanoid biosynthesis, <z:chebi fb="0" ids="3098">bile acid</z:chebi> biosynthesis, <z:chebi fb="23" ids="18059">lipid</z:chebi>, amino acid and nucleotide metabolism </plain></SENT>
</text></document>